发明名称 NEW FUSED IMIDAZOLE DERIVATIVE
摘要 PROBLEM TO BE SOLVED: To provide a compound having a DPPIV (dipeptidyl peptidase IV) inhibitory activity useful as a treating/preventing/improving agent of diseases of diabetes mellitus, etc. SOLUTION: This fused imidazole compound is expressed by general formula (wherein, T<SP>1</SP>is a single ring-formed or two ring-formed 4 to 12-membered heterocyclic ring which may have substituents, and containing one or two nitrogen atoms in the ring; X is a 1-6C alkyl which may have substituents; Z<SP>1</SP>, Z<SP>2</SP>are each independently N or a group expressed by formula: CR<SP>2</SP>; and R<SP>1</SP>, R<SP>2</SP>are each independently H, a 1-6C alkyl which may have substituents or a 1-6C alkoxy which may have substituents) or its salts or its hydride. These new compounds exhibit excellent DPPIV inhibitory activities. COPYRIGHT: (C)2005,JPO&NCIPI
申请公布号 JP2005145951(A) 申请公布日期 2005.06.09
申请号 JP20040249414 申请日期 2004.08.30
申请人 EISAI CO LTD 发明人 YOSHIKAWA SEIJI;EMORI EITA;MATSUURA FUMIYOSHI;CLARK RICHARD;IKUTA HIRONORI;KIRA KAZUNOBU;YASUDA NOBUYUKI;NAGAKURA TEI;YAMAZAKI KAZUTO
分类号 C07D471/04;A61K31/496;A61K31/5025;A61K31/522;A61K31/5377;A61K31/541;A61P1/00;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P15/00;A61P15/08;A61P19/02;A61P19/10;A61P29/00;A61P31/18;A61P35/00;A61P37/00;A61P37/02;A61P37/08;A61P43/00;C07D473/04;C07D473/06;C07D473/18;C07D473/22;C07D473/24;C07D473/30;C07D473/36;C07D473/40;C07D487/04;C07D491/14;(IPC1-7):C07D471/04;A61K31/502 主分类号 C07D471/04
代理机构 代理人
主权项
地址